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Aim:  The  aim  of  this  study  is simulation  of  the  proton  depth-dose  distribution  and  dose  evaluation  of
secondary  particles  in  proton  therapy  of brain  tumor  using  the GEANT4  and  FLUKA  Monte  Carlo  codes.
Background:  Proton  therapy  is a treatment  method  for  variety  of tumors  such  as  brain  tumor.  The  most
important  feature  of  high  energy  proton  beams  is  the  energy  deposition  as a Bragg  curve  and  the possi-
bility  of creating  the  spread  out Bragg  peak  (SOBP)  for full  coverage  of the  tumor.
Materials  and  methods:  A  spherical  tumor with  the  radius  of  1  cm  in the brain  is  considered.  A SNYDER
head  phantom  has  been  irradiated  with  30−130 MeV  proton  beam  energy.  A PMMA  modulator  wheel  is
used  for  covering  the  tumor.  The  simulations  are  performed  using  the  GEANT4  and  FLUKA  codes.
Results:  Using  a modulator  wheel,  the  Spread  Out  Bragg  Peak  longitudinally  and laterally  covers  the  tumor.Monte carlo simulations. Flux and  absorbed  dose  of  secondary  particles  produced  by nuclear  interactions  of  protons  with  elements
in  the  head  are considerably  small  compared  to protons.
Conclusions:  Using  76.85  MeV proton  beam  and  a modulator  wheel,  the  tumor  can  be treated  accurately
in  the  3-D,  so  that  the distribution  of proton  dose  in the  surrounding  tissues  is very low.  The  results  show
that  more  than  99% of  the  total  dose  of secondary  particles  and  protons  is  absorbed  in the  tumor.

















Research on the use of accelerator-produced proton beams in
radiation therapy, which has been ongoing since 1946,1 has been
vastly progressed in recent years.2–4 Proton therapy is one of the
external radiation therapy techniques to treat deep-seated tumors.
Proton therapy takes advantage of the maximum and minimum
dose reaching the tumor and the healthy tissue surrounding it,
respectively.5 Comparison of proton therapy with advanced photon
therapy methods such as intensity-modulated radiotherapy (IMRT)
and volumetric modulated arc therapy (VMAT) shows that proton
therapy provides better dose distributions and has a dosimetric
advantage over photon therapy.6–8
The charged particles, such as protons, when passing through
the material lose their energy, which can be expressed by Bethe-
Bloch equation.9 The Bragg curve can be obtained by plotting the
linear energy transfer (LET) of the charged particle as a function
of depth in the stopping material. At the end range of the charged
particles, LET reaches its maximum and then it quickly becomes
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1507-1367/© 2020 Greater Poland Cancer Centre. Published by Elsevier B.V. All rights resero. The very maximum is called Bragg peak.10 Bragg curve can be
sed in radiation therapy so that the Bragg peak is placed exactly
t the tumor site. For large tumors, Bragg peak must cover the
umor size, namely Spread Out Bragg Peak (SOBP). The SOBP is
btained by adding several Bragg peaks that are created at differ-
nt depths.11–14 In order to do this, there are two main methods,
amely passive scattering and active scanning.15–17 In the process
f broadening the Bragg peak (creating SOBP) by using the passive
cattering method, a range modulator is used in the proton beam
ine. This is because the geometry and the properties of the mod-
lator are important in creating an equivalent dose distribution in
he tumor volume.18,19
In order to model the proton therapy treatment, the codes based
n the Monte Carlo method are used. Numerous investigations on
he proton therapy planning simulations have been carried out
sing the MCNPX (Monte Carlo N-Particle), GEANT4 (Geometry and
racking) and FLUKA codes.20–22 A range modulator wheel for pro-
on therapy in Italy has been simulated by the GEANT4 code as
mployed in the experiment.23Secondary particles are produced by the passage of protons
ithin the body and their inelastic nuclear interactions with the
uclei of the elements of different tissues are scrutinized. Most
f the important subatomic particles in this process are neutrons
erved.
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Table  1
Comparisons between the simulation results of the ranges of 75 MeV  proton beam
in  different materials and ICRU49 report.30













Fig. 1. Comparison of the dose distribution created by 108.8 MeV  proton beam in












7.3 10.3 8.8Compact Bone 4.921 4.902 4.984
and gamma-rays. The secondary particles can move and lose their
energy in various organs. The dose that is absorbed in other organs
from these particles can be dangerous. Hence, measuring the flux
and energy deposition of the secondary particles has an important
role in radiotherapy.24,25
Research has been done to optimize the material of the
two-layer modulator in proton therapy with the presence of het-
erogeneous lung tissue.26 Simulation of a slab head phantom has
been conducted for evaluation of energy deposition, secondary
particle production, range straggling and multiple scattering in
proton therapy of brain tissue.25,27 In these papers, the geome-
try of the head phantom is not real and more attention has been
paid to the combination of the elements and the arrangement of
the tissues. Phantom design and dosimetric characterization for
multiple simultaneous cell irradiations have been performed for
proton therapy of head and neck cancer with active pencil beam
scanning.28 In treatment planning, some parameters should be
considered, such as the presence of inhomogeneity in tissue, the
geometric shape of the phantom, the dose of primary particles
and secondary particles in the tumor region and other tissues, etc,
which were considered in this article.
The aim of this study was to calculate the total absorbed dose in
different tissues of the SNYDER head phantom in the proton therapy
of brain cancer using the GEANT4 and FLUKA Monte Carlo codes.
By overlapping the pristine Bragg curves, a SOBP was  created that
covers the tumor. The energy spectrum and absorbed dose of the
major secondary particles produced in nuclear reactions in the head
phantom, gamma  rays and neutrons were also calculated. Simula-
tions have focused on the 3-dimensional (3D) coverage of the brain
tumor while healthy brain tissue absorbs less radiation.
2. Materials and methods
2.1. Comparison of the Monte Carlo simulations and
experimental results
A rectangular cube water phantom with dimensions of
40 × 30 × 30 cm3, which is irradiated with 108.8 MeV  protons, was
simulated using the GEANT4 toolkit by Park et al. and compared
with experimental results.29 In this paper a 40 × 30 × 30 cm3 rect-
angular cube of water irradiated with 108.8 MeV  protons was
simulated to evaluate the simulation results. The cubic voxel size
was selected with dimensions of 1 × 1 × 1 mm3 to obtain the dose
in each voxel. The Bragg curves obtained from simulation with the
FLUKA code and GEANT4 toolkit with experimental results were
shown in Fig. 1. It can be seen that there is a good agreement
between the simulation results and the experimental results.
To further evaluate the simulations, phantoms of water, PMMA,
soft tissue and compact bone were simulated with dimensions sim-
ilar to those mentioned above. The phantoms were irradiated with
75 MeV  proton beams and the Continuous Slowing Down Approx-
imation range (CSDA range) of the protons was calculated in each
phantom using the FLUKA code and GEANT4 toolkit. The results
of the simulations and the International Commission on Radiation
Units and Measurements report 49 (ICRU49)30 are shown in Table 1.
s
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928ig. 2. Schematic view of the SNYDER head phantom used for proton therapy sim-
lations.
he results were in agreement with each other and the ICRU49
esults.
.2. Head phantom definition
A SNYDER head phantom was  used as shown in Fig. 2. The head
hantom consists of the skin, skull, brain and tumor. The Snyder














































= 1 (3)The thickness of the skin was  considered to be 0.5 cm and the
kull has a variable thickness between 0.6 cm–2.8 cm.  To investi-
ate the treatment of a brain tumor using a proton beam, a spherical
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Table  2
Elemental composition, atom fractions and densities of materials used in the simulations.32






































The characteristics of the range modulator used in the simulations.
Spanning angle
(degree)




































































































































tumor with a radius of 1 cm at 1 cm from the surface of the brain was
considered in the Snyder head phantom. Elemental compositions
and atom fractions for the skin, skull and brain were taken from the
Compendium of Material Composition Data for Radiation Transport
Modeling32 and are shown in Table 2. Elemental composition of the
tumor was contrived to be the same as the brain tissue composition.
Simulations have been done using the GEANT4 and FLUKA codes.
GEANT4 is a versatile C++ Monte Carlo simulation tool kit which
simulates all kinds of particles. The G4VUserDetectorConstruction
class was used to design the geometry using GEANT4 code. The
material definitions using the G4Material class were in accordance
with Table 2. A mono-energetic proton surface source was  sim-
ulated as a disk with a radius of 1 cm and a distance of 17.5 cm
from the center of the tumor and it was designed so that the pro-
ton beam penetrates the brain from the top of the phantom in the
direction of the + Z axis. G4GeneralParticleSource class was  used
to simulate the source and generate the primary particles (pro-
tons) in the GEANT4 code. This class allows users to define spectral
sources and sources with different spatial distributions. The phys-
ical reference QGSP INCLXX was used to transport particles into
matter and to consider interactions and production of secondary
particles. This physical reference is for interactions involving pro-
tons and neutrons with energy of less than 3 GeV and is based
on experimental information and has been proposed for medi-
cal and industrial applications. Boxmesh was used to obtain the
Bragg curves in GEANT4. To obtain the secondary particles, several
classes of the G4VPrimiiveScorer class were derived and recorded
by the G4MultiFunctionalDetector. Each of these classes has a
G4THitsMap object and records a value as a result.33 In the simula-
tion using the FLUKA code (version 2011.2c), geometry and source
were designed exactly like simulations in the GEANT4 toolkit. The
simulations were done in the HADROTHE mode, which was the
most similar to the simulations done using the GEANT4 toolkit. This
code is a general purpose tool for calculations of particle transport
and interactions with materials. FLUKA can simulate the interaction
and propagation in matter of about 60 various particles with high
accuracy.34 The number of protons transported in each simulation
in both codes was 2 × 107 and the error values were less than 1%.
2.3. Simulation of a modulator
Proton deposits a small dose on its way when it enters the body.
With increasing the depth and reducing the speed, the absorbed
dose in the tissue increases. At the end of the proton range, the
protons are stopped, albeit the absorbed dose rises to a peak. It is
called the Bragg peak. The beam can be adjusted so that the Bragg
peak is placed at the tumor site. The width of the Bragg peak is
not enough to cover large tumors. The proton energy is changed
by passing the beam through a modulator and many Bragg peaks
occur at various depths. The Spread Out Bragg Peak was  obtained
from the superposition of multiple Bragg peaks. In this work, the
SOBP was generated when the proton beam hits a wheel-shaped
Poly Methyl Methacrylate (PMMA) as a range modulation. The
PMMA was located perpendicular to the proton beam direction and
rotating around the proton beam direction. The modulator has dif-













tep so that the protons pass thorough different thicknesses and
onsequently several Bragg peaks are produced. Without using a
odulator, the Bragg peak of 76.85 MeV  proton beam was placed
t the end of the tumor volume (in the direction of the dropped
rotons on the tumor). From the collision of the 76.85 MeV  pro-
on beam with different thicknesses of a modulator, several Bragg
eaks are created in the tumor region. With increasing the thickness
f the modulator, the created Bragg peaks cover the entire tumor
olume. The thickness of the PMMA  changes from 0 to 16.8 mm  in
5 steps meaning that the thickness increases by 0.7 mm at each
tep. The Spread Out Bragg Peak was obtained using the superpo-
ition of pristine Bragg curves with different weight coefficients.,
ragg curves were assembled together according to the following
elation23:
1Di1 + w2Di2 + . . . + wNDiN = D0 i = 1, 2, . . .N (4)
here wi parameters are the weight coefficients which are dimen-
ionless and calculated using MATLAB software. Di parameters are
he proton dose at each Bragg curve at a certain depth. D0 is a con-
tant value and related to the amount of dose in the SOBP region. N
s the number of equations and represents the number of pristine
ragg curves. The role of each Bragg peak in creating the SOBP is
roportional to the spanning angle of each thickness. In this mod-
lator, the sum of weight coefficients is equivalent to 360 degrees.
hus, the spanning angle associated with each thickness of the
odulator was  calculated. Different thicknesses of PMMA  create
 continuous spectrum of the absorbed dose in the tumor region.
hese calculated angles and weights are shown in Table 3.
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Fig. 3. Proton absorbed dose as a function of depth in the head phantom from
protons with different energies using GEANT4 code.
Table 4













FLUKA 4.13 0.07 0.41 0.1
Fig. 4. Comparison of the Spread Out Bragg Peaks created by 76.85 MeV  proton
beam, using GEANT4 and FLUKA codes.
Fig. 5. Comparison of the lateral dose distribution of 76.85 MeV  proton beam at








was at the proton energy of 76.85 MeV. The energy deposition ofGEANT4 4.11 0.08 0.42 0.09
3. Results
3.1. Proton depth-dose calculation
Comparison of the simulated and measured dose distribution
created by 108.8 MeV  proton beam was carried out in the water
phantom. The simulation results and measured data are shown in
Fig. 1 and were in good agreement with each other. The CSDA ranges
of 75 MeV  proton beam in water, PMMA,  soft tissue and compact
bone were calculated using the FLUKA and GEANT4 codes and are
shown in Table 1. It can be seen that the simulation results were in
good agreement with the ICRU49 report.30 As already mentioned,
a spherical shaped tumor with the same composition of the brain
tissue has been irradiated from 30 MeV  to 130 MeV proton beam
along the beam with energy steps of 10 MeV. The absorbed dose of
the protons was calculated as a function of the depth of the brain in
rectangular voxels with a size of 2 × 2 × 0.1 mm3 using the GEANT4
and FLUKA codes. Fig. 3 illustrates the depth dose profiles.
By changing the energy of the proton beam, it can be seen that
the appropriate proton energy for treatment is 76.85 MeV. Con-
certing this energy, the Bragg peak was located exactly at the end
of the tumor volume. To achieve the flat dose distribution (Spread
Out Bragg Peak) in the tumor volume, a modulator was  designed
in the form of a wheel. This wheel is made of PMMA  and its thick-
ness is variable as shown in Table 3. The 76.85 MeV  proton beam
strikes the modulator and, therefore, a lot of Bragg peaks in differ-
ent depths of the brain are formed. Giving an appropriate weight
to each Bragg peak and adding them (According to Eq. 4), the SOBP
was obtained in the depth of the tumor. The resultant SOBPs are
shown in Fig. 4. Characteristics of Bragg curves obtained from the
two Monte Carlo codes are shown in Table 4. The range is the distal
region of the Bragg peak, the penumbra width is the difference of
80% and 20% absorbed dose in the distal region and FWHM is Full
Width at Half Maximum of the Bragg peaks.The lateral dose distribution in the tumor has also been simu-
lated as shown in Fig. 5. The penumbra width in SOBP is calculated
7
U
930ig. 6. Comparison of the proton absorbed dose in tumor, skin, skull and brain tis-
ues as a function of proton energy with the energy range from 30 MeV  to 130 MeV
sing GEANT4 code.
sing simulation codes and it is equal to 0.1 cm and 0.09 cm, which
re calculated by the FLUKA and GEANT4 codes, respectively.
The proton dose absorption in the tumor, skin, skull and brain
issues as a function of proton energy from 30 MeV  to 130 MeV  is
hown in Fig. 6. It can be seen that the maximum absorbed dose6.85 MeV  protons in the tumor has been calculated using FLUKA-
SRBIN and shown in Fig. 7.
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Fig. 7. Energy deposition (x,z) profile of 76.85 MeV  protons inside the tumor simu-
lated using FLUKA-USRBIN.
Table 5






























3.2. Secondary neutrons and photons production
Due to the non-elastic nuclear interaction of protons with
different elements inside the head, the secondary particles are
produced, characterized by two main groups including neutrons
and photons. The energy spectrum of the neutrons and photons
per incident proton for 76.85 MeV  proton beam were simulated
using the GEANT4 toolkit and shown in Fig. 8. The neutrons and
photons dose absorption in the tumor, skin, skull and brain tis-
sues produced by 76.85 MeV  proton beam is shown in Fig. 9. In
this figure, it can be seen that the dose of secondary particles
was absorbed more in the tumor region. The total fluxes of neu-
trons inside the head phantom were obtained as 2.52 × 10−3 1/cm3
and 1.93 × 10-3 1/cm3 and as for photons they were obtained
as 2.81 × 10−3 1/cm3 and 2.38 × 10-3 1/cm3 using the GEANT4
and FLUKA codes, respectively. The average energy of neutrons
obtained in the tumor, skin, skull, and brain were 11.87, 7.39, 7.57,
and 7.97 MeV, respectively. While these values for photons were
4.55, 3.49, 3.74 and 3.42 MeV, respectively. The absorbed dose of
secondary particles obtained were 0.00758 and 0.00693 Gy/proton
in the tumor, 0.000307 and 0.000263 Gy/proton in the brain,
0.000131 and 0.000105 Gy/proton in the skull, 0.000163 and
0.000140 Gy/proton in the skin, using the GEANT4 and FLUKA
codes, respectively.
The total absorbed doses of protons and secondary neutrons and




931ig. 9. Comparison of the secondary neutrons and photons absorbed dose in tumor,
kin, skull and brain tissues for 76.85 MeV proton beam energy using GEANT4 and
LUKA codes.
esults show that more than 99% of the total dose was absorbed in
he tumor.
. Discussion
From Fig. 3 it can be seen that by increasing the energy of the
roton beam, Bragg peaks were created inside the brain region andng energy, the range straggling increases and, therefore, the peaks
ecome shorter and wider.27 A spherical brain tumor was consid-
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The simulation results show that when the proton beam has energy
of 76.85 MeV, the Bragg peak was formed at the end of the tumor
region. Research shows that the location of the inhomogeneous tis-
sue does not affect the shape of the Brag curve, while it affects the
dose in the Bragg curve.35 Research has been done to use low Z
materials, such as PMMA, to change the range of protons and high
Z materials, such as Pb, to create lateral scattering.23,26 For treat-
ment planning, to create a SOBP in the tumor region, a modulator
with different thicknesses is required, which can be achieved by
using a modulator wheel. By placing a modulator wheel with dif-
ferent thicknesses of PMMA  in the path of the 76.85 MeV  protons,
a large number of Bragg peaks are formed in the tumor. Using the
appropriate proton beam energy and a modulator, the SOBP was
created that covers the entire tumor volume. The SOBP and lat-
eral dose distribution of 76.85 MeV  proton beam obtained using
the GEANT4 and FLUKA codes, shown in Figs. 4 and 5, were in good
agreement with each other.
The deposited energy of the primary protons in the brain tumor
is an important factor to determine the appropriate proton energy.
This factor can be calculated using the Monte Carlo codes by chang-
ing the proton beam energy. According to the considered geometry,
the simulation results show that the energy deposition in the tumor
increases with increasing the proton energy up to 76.85 MeV, after
which it decreases because of the deposition of a portion of the pro-
ton energy in the other organs surrounding the tumor. Figs. 6 and 7
show that, at 76.85 MeV, the tumor absorbs the maximum dose and,
also, the healthy tissues absorb the minimum dose emitted by the
protons. In fact, the proton absorbed dose values in the tumor, brain,
skull and skin were 99.2%, 0.41%, 0.16% and 0.23%, respectively.
Neutrons and photons are the most important secondary parti-
cles formed by the interaction of protons with elements. Positron
emitter isotopes are also produced from non-elastic nuclear reac-
tions of the primary protons with stable nuclei such as 12C, 35Cl,
16O and other elements in the tissue from the (p,pn) reactions.36
Figs. 8a and 8b show the energy spectrum of secondary neutrons
and photons. The neutron energy spectra have a peak at low ener-
gies. The photon energy spectra have some peaks which are related
to the characteristic gamma ray energies emitted from the excited
carbon, chlorine and oxygen.25 Nuclei such as 11C, 34Cl and 15O are
positron emitters. After the positive beta decay, the positron moves
in the tissues and loses its energy due to the coulomb interaction.
Close to the end of its track, the positron combines with an atomic
electron, the two annihilate each other, and at least two  0.511 MeV
photons appear in opposite directions. By revealing these photons
using PET camera, it can be possible to determine the location of
the Bragg peak, which is very important in proton therapy.
The energy deposition of protons in a slab head phantom and
calculated secondary neutrons and photons produced in proton
therapy of the human brain have been evaluated using the MCNPX
code.25 They changed the energy from 40 MeV  to 140 MeV. They
found that for high energy proton beams, the amount of escaped
energy by neutrons is almost 10 times larger than that by photons
and it is around 1% at 110 MeV  proton beam energy.
In this study, the results show that the average energy of neu-
trons in tumor, brain, skull and skin with a factor of 2.61, 2.33,
2.02, and 2.11 were higher than the average energy of photons,
respectively. The absorbed dose of the secondary particles in dif-
ferent tissues that were simulated using the GEANT4 and FLUKA
codes were in agreement with each other. The results of the sim-
ulations using the GEANT4 code show that the absorbed dose of
secondary particles in tumor were 24.69, 57.86 and 46.50 times
more than the absorbed dose in the brain, skull and skin, respec-
tively. Mneanwhile these results obtained using the FLUKA code
were 26.35, 66 and 49.50, respectively. It can be seen from Table 5
that the total absorbed dose in the tumor was 249.18 and 177.02
times higher than in the brain, 1566.58 and 1564.96 times higher
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han in the skull, 2126.83 and 1715.44 times higher than in the skin,
alculated using the GEANT4 and FLUKA codes, respectively.
. Conclusions
A SNYDER head phantom consisting of the skin, skull, brain and
lso tumor has been simulated using the GEANT4 and FLUKA codes.
he brain tumor is considered as a sphere with a radius of 1 cm and
s located 2.1 cm under the skin with the same elemental compo-
ition as the brain. The results show that by modulation of pristine
ragg peaks corresponding to the 76.85 MeV  proton beam energy
ith their relevant weights, the SOBP can be obtained that longitu-
inally and laterally covers the tumor volume. The absorbed dose
f the protons in the skin, skull, tumor and brain tissues was cal-
ulated for 76.85 MeV  proton energies. It was  found that 99.2% of
he total dose for 76.85 MeV  proton beam is absorbed in the tumor
olume. Neutrons and photons have been considered as the most
mportant secondary particles produced in the non-elastic nuclear
eactions of the protons whose flux and absorbed dose have been
alculated in different tissues. The absorbed dose of the protons and
econdary neutrons and photons has been calculated in tumor, skin,
kull and brain tissues. It was  found that more than 99% of the total
ose is absorbed in the tumor. Ultimately the tumor is irradiated in
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